U.S. Representatives Urge FDA to Reconsider Menthol Ban

Regulations by 2FIRSTS.ai
Jun.27.2023
U.S. Representatives Urge FDA to Reconsider Menthol Ban
US congressmen urge FDA to reconsider the proposed ban on menthol cigarettes and flavored cigars to prevent illegal trade.

According to a report by CSPdailynews, 20 members of the United States Congress have written to the Commissioner of the Food and Drug Administration (FDA), Robert Califf, stating that banning menthol cigarettes and flavored cigars will exacerbate the issue of illegal trade in tobacco products.

 

The FDA is expected to formally release the final regulations for new tobacco standards in August, however, the ban will not take effect for at least one year.

 

The letter stated that:

 

When Congress created the Tobacco Control Act in 2009, the intention was to enable the FDA to regulate the tobacco industry properly. If the ban were to result in a large illegal market, it would only increase the risk to the American people, lead to more crime, burden law enforcement agencies, and create more community conflict.

 

Lawmakers urged the FDA in a letter to take illegal markets seriously. The letter referenced that the FDA could meet the needs of adult consumers through regulatory measures and establish control measures to protect children from harm caused by these products.

 

We urge you to reconsider the proposed regulations by the FDA on menthol cigarettes and flavored cigars and to avoid further prohibitive actions that may fuel the expansion of the illegal market.

 

Previously, Califf admitted at a hearing of the House Agriculture, Rural Development, and FDA Appropriations Subcommittee that the FDA is unable to eliminate illegal e-cigarette products from the market.

 

Despite the FDA's efforts to regulate e-cigarette products since 2016, they have failed to bring order to this category. With a few exceptions, the majority of adult consumers' needs have not been met.

 

In April of this year, the Food and Drug Administration (FDA) submitted a status report on the progress of Pre-Market Tobacco Product Applications (PMTAs), stating that the review process is expected to be completed by the end of this year.

 

The agency has issued 45 marketing authorizations (MGOs) for tobacco products that have gone through the PMTA process, but no marketing authorizations have been issued for any other flavored products besides tobacco.

 

The letter states that the ban on menthol cigarettes will prevent approximately one-third of all cigarettes currently sold in the United States from entering into the legal and regulated distribution system. Lawmakers are concerned that this ban could lead to an illegal market similar to e-cigarette products, further increasing the burden on law enforcement.

 

The letter also mentions examples from Massachusetts and California, where the illegal tobacco market has continued to grow after the ban on flavored tobacco sales. The letter states that a large illegal e-cigarette market has now developed throughout the United States.

 

The letter stated that these e-cigarette products were smuggled illegally through the US borders and ports, sold in violation of state and local criminal laws, and sold without age verification procedures in place.

 

As of now, the FDA has not responded to the evaluation request from CSP.

 

Reference:

 

Congress members are urging the Food and Drug Administration (FDA) to review their proposal to ban menthol cigarettes in the United States.

 


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

BAT Restructuring to Affect 9,000 Roles as Tobacco Group Pushes Cost Cuts and AI
BAT Restructuring to Affect 9,000 Roles as Tobacco Group Pushes Cost Cuts and AI
British American Tobacco (BAT) plans to cut about 5,500 jobs globally and shift around 3,500 roles to strategic partners by the end of 2026, affecting about 9,000 roles in total, as the company seeks to simplify operations, strengthen technology capabilities and deliver £600 million in annual savings by 2028.
BAT
Jun.29
Scotland Plans to Remove Business Rates Relief From Vape Shops From 2027
Scotland Plans to Remove Business Rates Relief From Vape Shops From 2027
The Scottish Government plans to remove business rates relief from vape shops from April 1, 2027, saying the measure is intended to ensure vape retailers contribute to the high street and align rates relief with public health commitments, while the impact on convenience stores that sell vaping products remains unclear.
News
Jun.26 by 2Firsts Perspectives
BAT Estimates U.S. Unauthorized Vape Market at $9.4 Billion, Plans New Vuse and Velo Launches After FDA Enforcement Shift
BAT Estimates U.S. Unauthorized Vape Market at $9.4 Billion, Plans New Vuse and Velo Launches After FDA Enforcement Shift
British American Tobacco (BAT) CEO Tadeu Marroco said the U.S. unauthorized vape market is worth about £7 billion, or US$9.43 billion. Following a shift in FDA enforcement policy, BAT plans to launch flavored Vuse products in the third quarter and an updated Velo pouch in August or September.
Jun.15
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
British American Tobacco (BAT) shares rose sharply on May 12 after the U.S. Food and Drug Administration signaled it would deprioritize enforcement against certain unauthorized e-cigarette and nicotine pouch products with accepted premarket applications. Investors viewed the move as favoring established players such as BAT’s Vuse and Velo brands.
BAT
May.13
Nicotine Pouches Lead U.S. Tobacco Growth as Vape Sales Decline
Nicotine Pouches Lead U.S. Tobacco Growth as Vape Sales Decline
New convenience store industry data show nicotine pouches have become the primary growth driver in the tobacco category, with oral nicotine sales rising nearly 30% over the past year while vape sales declined.
Business
Jun.05
Data|China’s May Vape Exports Fall 10.3%; January–May Shipments Slip 0.9%
Data|China’s May Vape Exports Fall 10.3%; January–May Shipments Slip 0.9%
China’s vape-related exports fell 10.25% year on year in May 2026, marking a second consecutive monthly decline, although exports recovered modestly from April. January-May exports totaled US$4.018 billion, down 0.86% from a year earlier and broadly in line with 2025 levels.
Special Report
Jun.29